Bupivacaine Effectiveness and Safety in SABER® Trial
NCT01052012
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
331
Enrollment
INDUSTRY
Sponsor class
Conditions
Postoperative Pain
Abdominal Surgery
Interventions
DRUG:
SABER-Bupivacaine
DRUG:
Bupivacaine HCl
DRUG:
SABER-Placebo
Sponsor
Durect
Collaborators
[object Object]
[object Object]